PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-972.42%
Both yoy net incomes decline, with CRON.TO at -113.79%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
10.12%
Some D&A expansion while CRON.TO is negative at -23.93%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-68.79%
Negative yoy deferred tax while CRON.TO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-4.13%
Negative yoy SBC while CRON.TO is 6.64%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
49.04%
Less working capital growth vs. CRON.TO's 624.40%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-68.67%
Both yoy AR lines negative, with CRON.TO at -379.98%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-46.76%
Both reduce yoy inventory, with CRON.TO at -176.23%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
172.84%
Lower 'other working capital' growth vs. CRON.TO's 1204.72%. David Dodd would see fewer unexpected short-term demands on cash.
483.14%
Well above CRON.TO's 83.07%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
55.76%
Some CFO growth while CRON.TO is negative at -82.08%. John Neff would note a short-term liquidity lead over the competitor.
-21.24%
Negative yoy CapEx while CRON.TO is 52.74%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
128.89%
Acquisition growth of 128.89% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-102.06%
We reduce yoy other investing while CRON.TO is 329.37%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-379.04%
We reduce yoy invests while CRON.TO stands at 232.07%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-520.47%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both yoy lines negative, with CRON.TO at -375.60%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.